gogo

State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization. (Record no. 173809)

MARC details
000 -LEADER
fixed length control field 03809nam a22006498i 4500
001 - CONTROL NUMBER
control field BDZ0027302550
003 - CONTROL NUMBER IDENTIFIER
control field StDuBDS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20180923150156.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 160829s2016 nyua f b 001|0|eng|d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780841230293 (hbk.) :
Terms of availability £115.00
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0841230293
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)960906981
040 ## - CATALOGING SOURCE
Original cataloging agency StDuBDS
Language of cataloging eng
Transcribing agency StDuBDS
Modifying agency StDuBDSZ
Description conventions rda
050 #0 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QR186.85
Item number .S73 2016
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Source ukslc
072 #7 - SUBJECT CATEGORY CODE
Subject category code PSB
Source thema
072 #7 - SUBJECT CATEGORY CODE
Subject category code MKG
Source thema
072 #7 - SUBJECT CATEGORY CODE
Subject category code PNN
Source thema
072 #7 - SUBJECT CATEGORY CODE
Subject category code TDCW
Source thema
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Edition number 616.0798 SCH
245 00 - TITLE STATEMENT
Title State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization.
Number of part/section of a work Volume 2,
Name of part/section of a work Biopharmaceutical characterization /
Statement of responsibility, etc. edited by John E. Schiel, Darryl L. Davis, Oleg V. Borisov.
246 30 - VARYING FORM OF TITLE
Title proper/short title Biopharmaceutical characterization
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. New York :
Name of publisher, distributor, etc. Oxford University Press,
Date of publication, distribution, etc. 2016.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Washington, DC :
Name of producer, publisher, distributor, manufacturer American Chemical Society
Date of production, publication, distribution, manufacture, or copyright notice 2104
300 ## - PHYSICAL DESCRIPTION
Extent 448 pages :
Other physical details illustrations ;
Dimensions 23 cm.
490 1# - SERIES STATEMENT
Series statement ACS symposium series
490 1# - SERIES STATEMENT
Series statement State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization ;
Volume/sequential designation volume 2
490 1# - SERIES STATEMENT
Series statement ACS symposium series ;
Volume/sequential designation 1201
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note Includes bibliographical references and index.
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note 1.Determination of the NIST mAB primary structure. Trina Formolo ... [et al] -- 2.Sequence varianst and sequence variant analysis in biotherapeutic protins. Oleg V. Borisov ... [et al] -- 3.Structural elucidation of post-translational modifications in monoclonal antibodies. Wenzhou Li ... [et al] -- 4.Orthogonal technologies for NIST mAB N-Glycan structure elucidation and quantitation. Justin M. Prien ... [et al] -- 5.Separation methods and orthogonal techniques. David A. Michels ... [et al] -- 6.Biophysical techniques for characterizing the higher order structure and interactions of monoclonal antibodies. Yatin Gokarn ... [et al] -- 7.Developability assessment of a proposed INST monoclonal antibody.Dorina Saro ... [et al] -- 8.Protein particles (0.01 æm, 0.01 æm. Dean C. Ripple and Linda O. Narhi -- 9.Analytical methods for the measurement of host cell proteins and other process-related impurities. Kesh Prakahs and Weibin Chen.
520 8# - SUMMARY, ETC.
Summary, etc. This volume looks at the characterisation of monoclonal antibodies (mAbs), focusing both on general aspects, techniques and regulatory concerns common to any recombinant protein as well as specific analytical results. It therefore serves as both a foundational body of NISTmAb product knowledge as well as an evaluation of its suitability as an industry-appropriate reference material.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoglobulins
General subdivision Therapeutic use
9 (RLIN) 759
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Monoclonal antibodies.
9 (RLIN) 758
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical biotechnology.
9 (RLIN) 757
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biopharmaceutics.
9 (RLIN) 756
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Monoclonal antibodies.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Health and Wellbeing.
Source of heading or term ukslc
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biochemistry
Source of heading or term thema
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmacology
Source of heading or term thema
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Organic chemistry
Source of heading or term thema
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pharmaceutical chemistry & technology
Source of heading or term thema
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schiel, John E.,
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Davis, Darryl L.,
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Borisov, Oleg,
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Schiel, John E.,
Relator term editor
9 (RLIN) 760
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Davis, Darryl L.,
Relator term editor
9 (RLIN) 761
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Borisov, Oleg,
Relator term editor
9 (RLIN) 762
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element American Chemical Society,
Relator term associated with work.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title ACS symposium series ;
Volume/sequential designation 1201
9 (RLIN) 764
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization ;
Volume/sequential designation v. 2
9 (RLIN) 763
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Long Loan
948 ## - LOCAL PROCESSING INFORMATION (OCLC); SERIES PART DESIGNATOR (RLIN)
h (OCLC) NO HOLDINGS IN YQA - 1 OTHER HOLDINGS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Cost, normal purchase price Total Checkouts Full call number Barcode Date last seen Cost, replacement price Price effective from Koha item type
    Dewey Decimal Classification     TUS: Midlands, Main Library TUS: Midlands, Main Library Athlone General Lending 17/10/2017 2 121.67   616.0798 SCH 223872 25/06/2019 143.89 17/10/2017 Long Loan

Powered by Koha